Activation of MAP kinase by MC4-R through PI3 kinase.

Regul Pept

Department of Metabolic Research-Obesity, Merck Research Laboratories, Merck and Co., P.O. Box 2000, RY80M-213 Rahway, NJ 07065, USA.

Published: August 2004

The melanocortin 4 receptor (MC4-R) is a Galpha s-coupled receptor known to increase cAMP production following agonist stimulation. We demonstrate that the mitogen-activated protein kinases p42 (ERK2) and p44 (ERK1) are also activated by MC4-R following treatment with the MC4-R agonist NDP-alpha-MSH in stably transfected CHO-K1 cells. This time- and dose-dependent response is abolished by the MC4-R antagonist SHU-9119. p42/p44 MAPK activation is blocked by the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY294002 but not by the protein kinase A (PKA) inhibitor Rp-cAMPS, indicating that that signal activating the p42/p44 MAPK pathway is conveyed through inositol triphosphate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.regpep.2004.02.018DOI Listing

Publication Analysis

Top Keywords

p42/p44 mapk
8
mc4-r
5
activation map
4
map kinase
4
kinase mc4-r
4
mc4-r pi3
4
pi3 kinase
4
kinase melanocortin
4
melanocortin receptor
4
receptor mc4-r
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!